Nader Francois

DirectorTalaris Therapeutics, Inc. (TALS) · full profile →Form 4/A · filed Sep 13, 2022
Net Buying
Open-Market Buys
$500K
Open-Market Sells
$0
Net Open-Market Flow
$500K
Transactions
7
7 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 25, 2022Other(J)139K$00
Jul 25, 2022Other(J)139K$0387K
Jul 21, 2022Buy(P)37K$3.72$136K139K
Jul 21, 2022Other(J)248K$0248K
Jul 21, 2022Other(J)248K$0147K
Jul 20, 2022Buy(P)52K$3.62$188K102K
Jul 19, 2022Buy(P)50K$3.52$176K50K

Transaction Codes

J
Other acquisition / disposition
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000899243-22-030924) within minutes of acceptance. Every field above traces to the original document. Verify it directly: